Immediate Impact

3 by Nobel laureates 12 from Science/Nature 53 standout
Sub-graph 1 of 24

Citing Papers

Biomarker Changes during 20 Years Preceding Alzheimer’s Disease
2024 Standout
A versatile CRISPR-Cas13d platform for multiplexed transcriptomic regulation and metabolic engineering in primary human T cells
2024 Standout
2 intermediate papers

Works of Daniel L. Crimmins being referenced

Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease
2015
Decay Accelerating Activity of Complement Receptor Type 1 (CD35)
1999

Author Peers

Author Last Decade Papers Cites
Daniel L. Crimmins 129 228 65 111 8 496
Renata P. Leite 83 135 51 51 8 499
L Stellitano 177 91 23 32 12 506
Camille Olechowski 87 179 98 47 10 456
William A. Banks 105 109 68 41 7 534
Tracy Reynolds 176 195 187 28 21 574
Antonia Clarke 183 98 69 101 15 478
R Arana 107 240 67 17 12 562
Clayton A. Wiley 109 162 123 46 14 472
Yuki Hayano 136 85 113 71 6 463
Tibor Nánási 257 158 46 20 10 565

All Works

Loading papers...

Rankless by CCL
2026